Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
World Journal of Gastroenterology|August 2, 2014
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Gábor FirneiszOrvosi Hetilap|November 23, 2025
[The role of the PNPLA3 gene rs738409 variant in the spectrum of metabolic dysfunction associated steatotic liver diseases]Ákos Nádasdi, Gábor FirneiszOrvosi Hetilap|July 5, 2012
[Type 1 diabetes mellitus: most recent advances in its pathogenesis and treatment]András Zóka, Anikó Somogyi, Gábor FirneiszWorld Journal of Gastroenterology|September 28, 2016
Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesFerenc Sipos, Gábor Firneisz, Györgyi MűzesOrvosi Hetilap|November 13, 2018
[Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016]Ákos Nádasdi, Anikó Somogyi, Péter Igaz, et al.Orvosi Hetilap|May 19, 2010
[Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison]Tímea Varga, Gábor Firneisz, Géza Nagy, et al.Cardiovascular Diabetology|March 22, 2023
PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid contentÁkos Nádasdi, Viktor Gál, Tamás Masszi, et al.Pathology Oncology Research : POR|August 16, 2018
Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic StressKatalin Kiss, Eszter Regős, Kristóf Rada, et al.Diabetology & Metabolic Syndrome|July 27, 2022
Combined effect of pancreatic lipid content and gene variants (TCF7L2, WFS1 and 11BHSD1) on B-cell function in Middle Aged Women in a Post Hoc AnalysisÁkos Nádasdi, Viktor Gál, Tamás Masszi, et al.Bioinformatics (Oxford, England)|September 27, 2003
Identification and quantification of disease-related gene clustersGábor Firneisz, Idit Zehavi, Csaba Vermes, et al.Pageof 4